Study is Designed to Assess the Safety and Tolerability of AZD4547 at Increasing Doses in Patients With Advanced Tumours
Status:
Terminated
Trial end date:
2015-03-05
Target enrollment:
Participant gender:
Summary
This study is primarily designed to assess the safety and tolerability of AZD4547 at
increasing doses in patients with advanced solid malignancies and for whom no standard
medication options are available. It also assesses the blood levels and action of AZD4547 in
the body over a period of time.